文献速递青光眼白内障与屈光手术

口服乙酰唑胺对青光眼白内障术后眼压升高的预防效果

Prophylactic Effect of Oral Acetazolamide against Intraocular Pressure Elevation after Cataract Surgery in Eyes with Glaucoma.
PubMed 文献 · Ophthalmology · 2017-01-19

一项随机临床研究纳入90只原发性开角型青光眼(POAG)患眼,比较术前1小时口服乙酰唑胺500 mg、术后3小时口服乙酰唑胺500 mg及不服用乙酰唑胺对超声乳化术后眼压的影响。结果显示术前给药组在术后1至24小时眼压显著低于其他两组,且眼压升高超过术前100%的发生率显著更低(P=0.0459)。

要点

  • POAG患眼超声乳化术后3至7小时出现眼压显著升高,24小时下降。
  • 术前1小时口服乙酰唑胺500 mg在术后1至3小时眼压显著低于术后给药组和不给药组(P≤0.0031)。
  • 术前给药组眼压升高超过100%的发生率为3.3%,显著低于术后给药组23.3%和不给药组26.6%(P=0.0459)。

主要发现

  • 术前1小时和手术结束时平均眼压各组间无显著差异。
  • 所有组术后3至7小时平均眼压显著升高,24小时下降。
  • 术后1和3小时,术前给药组平均眼压显著低于术后给药组和不给药组(P≤0.0031)。
  • 术后5、7和24小时,术前给药组和术后给药组眼压均显著低于不给药组(P≤0.0224)。
  • 眼压升高超过术前100%的发生率:术前给药组1眼(3.3%),术后给药组7眼(23.3%),不给药组8眼(26.6%);术前给药组显著更低(P=0.0459)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To confirm the prophylactic effect of oral acetazolamide against increased intraocular pressure (IOP) in the period immediately after cataract surgery in eyes with primary open-angle glaucoma (POAG) and to evaluate the appropriate administration time of oral acetazolamide to prevent IOP elevation. DESIGN: Randomized clinical study. PARTICIPANTS: Ninety eyes of 90 patients with well-controlled POAG scheduled for phacoemulsification. METHODS: Eyes were assigned randomly to 1 of 3 groups: (1) oral acetazolamide (500 mg) administration 1 hour preoperatively, (2) oral acetazolamide (500 mg) administration 3 hours postoperatively, or (3) no acetazolamide administration. Intraocular pressure was measured using a rebound tonometer 1 hour preoperatively, at the conclusion of surgery (adjusted in the range between 15 and 25 mmHg), and 1, 3, 5, 7, and 24 hours postoperatively. The incidence of eyes with IOP elevation more than 100% above the preoperative IOP was compared. MAIN OUTCOME MEASURES: Postoperative IOP and incidence of eyes with marked IOP elevation. RESULTS: Mean IOP 1 hour preoperatively and that at the conclusion of surgery did not differ significantly among groups. In all groups, mean IOP was significantly elevated from 3 to 7 hours postoperatively, and then decreased at 24 hours. At 1 and 3 hours postoperatively, mean IOP was significantly lower in the group receiving oral acetazolamide preoperatively than in the other 2 groups (postoperative administration or no administration; P ≤ 0.0031). At 5, 7, and 24 hours postoperatively, the IOP was significantly lower in both the preoperative and postoperative administration groups than in the nonadministration group (P ≤ 0.0224). Intraocular pressure elevation of more than 100% occurred in 1 eye (3.3%) in the preoperative administration group, 7 eyes (23.3%) in the postoperative administration group, and 8 eyes (26.6%) in the nonadministration group; the incidence was significantly lower in the preoperative administration group (P = 0.0459). CONCLUSIONS: Eyes with POAG experienced short-term IOP elevation from 3 to 7 hours after phacoemulsification. Oral acetazolamide administration 1 hour preoperatively significantly reduced the IOP elevation from 1 to 24 hours, while administration 3 hours postoperatively reduced the IOP elevation at 5 hours or more after surgery.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Hayashi K, Yoshida M, Manabe SI, et al. Prophylactic Effect of Oral Acetazolamide against Intraocular Pressure Elevation after Cataract Surgery in Eyes with Glaucoma. Ophthalmology. 2017. PMID: 28110949. doi:10.1016/j.ophtha.2016.12.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。